Drug intelligence / Profile preview

Sanjin tablets

Development stage
Phase 4
Lead developer
Guilin Sanjin Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Sanjin tablets are a traditional Chinese patent medicine used primarily for the treatment of acute uncomplicated lower urinary tract infections (UTIs), especially those presenting with symptoms such as dysuria, urinary urgency, frequency, and suprapubic pain. The formulation consists of five herbal ingredients—Rosae Laevigatae Radix, Smilacis Chinae Rhizoma, Melastomae Normalis Radix, Lygodii Herba, and Centellae Herba. Chemical profiling has identified over 190 compounds in the product; several have demonstrated antimicrobial and anti-inflammatory activities relevant to UTI management. Mechanistically, network pharmacology studies suggest that multiple active compounds in Sanjin tablets interact with a range of targets involved in infection and inflammation pathways. The drug is typically administered orally as film- or sugar-coated tablets[2][3][1].

Brand names
Sanjin tablets
Other names
SJT
02

Targets

NOS2 (Nitric Oxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))IL-6R (Interleukin-6 receptor subunit alpha)

Beyond the preview

Go deeper on Sanjin tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanjin tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call